September 9, 2021 Comments Off on New patent for Biocryst drug ORLADEYO Posted in: Patent Added Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are four patents protecting this drug. This drug has thirty-six…
The post New patent for Biocryst drug ORLADEYO appeared first on Drug…
September 9, 2021 Comments Off on New patent for Acrotech drug BELEODAQ Posted in: Patent Added Annual Drug Patent Expirations for BELEODAQ Beleodaq is a drug marketed by Acrotech and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent for Acrotech drug BELEODAQ appeared first on DrugPatent…
